These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 15386391

  • 1. Identification of differentially methylated CpG islands in prostate cancer.
    Yamada Y, Toyota M, Hirokawa Y, Suzuki H, Takagi A, Matsuzaki T, Sugimura Y, Yatani R, Shiraishi T, Watanabe M.
    Int J Cancer; 2004 Dec 10; 112(5):840-5. PubMed ID: 15386391
    [Abstract] [Full Text] [Related]

  • 2. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
    Pulukuri SM, Rao JS.
    Oncogene; 2006 Aug 03; 25(33):4559-72. PubMed ID: 16786000
    [Abstract] [Full Text] [Related]

  • 3. Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling.
    Chung W, Kwabi-Addo B, Ittmann M, Jelinek J, Shen L, Yu Y, Issa JP.
    PLoS One; 2008 Apr 30; 3(4):e2079. PubMed ID: 18446232
    [Abstract] [Full Text] [Related]

  • 4. p21WAF1/CIP1 gene is inactivated in metastatic prostatic cancer cell lines by promoter methylation.
    Bott SR, Arya M, Kirby RS, Williamson M.
    Prostate Cancer Prostatic Dis; 2005 Apr 30; 8(4):321-6. PubMed ID: 16276353
    [Abstract] [Full Text] [Related]

  • 5. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP, Harya NS, Hutzley J, Bacich DJ, Monzon FA, Chandran U, Dhir R, O'Keefe DS.
    Prostaglandins Other Lipid Mediat; 2007 Jan 30; 82(1-4):185-97. PubMed ID: 17164146
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC, Yu Y.
    Cancer Res; 2003 Jul 15; 63(14):4174-80. PubMed ID: 12874023
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
    Lee J, Lee MS, Jeoung DI, Kim YM, Lee H.
    Prostate; 2017 Mar 15; 77(4):350-360. PubMed ID: 27813113
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer.
    Zhao H, Shiina H, Greene KL, Li LC, Tanaka Y, Kishi H, Igawa M, Kane CJ, Carroll P, Dahiya R.
    Cancer; 2005 Jul 01; 104(1):44-52. PubMed ID: 15895377
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hypermethylation of CpG islands in primary and metastatic human prostate cancer.
    Yegnasubramanian S, Kowalski J, Gonzalgo ML, Zahurak M, Piantadosi S, Walsh PC, Bova GS, De Marzo AM, Isaacs WB, Nelson WG.
    Cancer Res; 2004 Mar 15; 64(6):1975-86. PubMed ID: 15026333
    [Abstract] [Full Text] [Related]

  • 16. Methylation of the retinoid response gene TIG1 in prostate cancer correlates with methylation of the retinoic acid receptor beta gene.
    Zhang J, Liu L, Pfeifer GP.
    Oncogene; 2004 Mar 18; 23(12):2241-9. PubMed ID: 14691453
    [Abstract] [Full Text] [Related]

  • 17. Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
    Sidiropoulos M, Pampalakis G, Sotiropoulou G, Katsaros D, Diamandis EP.
    Tumour Biol; 2005 Mar 18; 26(6):324-36. PubMed ID: 16254462
    [Abstract] [Full Text] [Related]

  • 18. Identification of 27 5' CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers.
    Hagihara A, Miyamoto K, Furuta J, Hiraoka N, Wakazono K, Seki S, Fukushima S, Tsao MS, Sugimura T, Ushijima T.
    Oncogene; 2004 Nov 11; 23(53):8705-10. PubMed ID: 15467763
    [Abstract] [Full Text] [Related]

  • 19. Lactoferrin CpG Island Hypermethylation and Decoupling of mRNA and Protein Expression in the Early Stages of Prostate Carcinogenesis.
    Porter CM, Haffner MC, Kulac I, Maynard JP, Baena-Del Valle JA, Isaacs WB, Yegnasubramanian S, De Marzo AM, Sfanos KS.
    Am J Pathol; 2019 Nov 11; 189(11):2311-2322. PubMed ID: 31499027
    [Abstract] [Full Text] [Related]

  • 20. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
    Zon G, Barker MA, Kaur P, Groshen S, Jones LW, Imam SA, Boyd VL.
    Anal Biochem; 2009 Sep 15; 392(2):117-25. PubMed ID: 19505431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.